ResearcherMoffitt Cancer CenterActive in the last 2 years
John Michael Bryant
Matched on ORCID iD 0000-0002-0207-1991; OpenAlex author ID A5043293845. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 6
- To irradiate or electroporate: how should we ablate pancreatic cancer? Co-author DOI 10.21037/tgh-24-164↗
- The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/jcm13226800↗
- Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer. Co-author DOI 10.1016/j.radonc.2023.109869↗
- Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic R… Co-author DOI 10.1177/10732748221150228↗
- Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation … Co-author DOI 10.1016/j.adro.2022.101045↗
- Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report. Co-author DOI 10.1016/j.meddos.2021.04.006↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jessica M. Frakes · 4 shared papers, 2022–2025 · strength 0.81
- Paper To irradiate or electroporate: how should we ablate pancreatic cancer? DOI 10.21037/tgh-24-164↗
- Paper The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma. DOI 10.3390/jcm13226800↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Sarah E. Hoffe · 4 shared papers, 2022–2025 · strength 0.81
- Paper To irradiate or electroporate: how should we ablate pancreatic cancer? DOI 10.21037/tgh-24-164↗
- Paper The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma. DOI 10.3390/jcm13226800↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Mokenge Peter Malafa · 4 shared papers, 2022–2025 · strength 0.81
- Paper To irradiate or electroporate: how should we ablate pancreatic cancer? DOI 10.21037/tgh-24-164↗
- Paper The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma. DOI 10.3390/jcm13226800↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Jason W. Denbo · 3 shared papers, 2022–2024 · strength 0.50
- Paper The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma. DOI 10.3390/jcm13226800↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Paper Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Re… DOI 10.1016/j.adro.2022.101045↗
- Michael David Chuong · 3 shared papers, 2021–2023 · strength 0.44
- Paper Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness i… DOI 10.1016/j.radonc.2023.109869↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Paper Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenoca… DOI 10.1016/j.meddos.2021.04.006↗
- Pamela Joy Hodul · 2 shared papers, 2023–2024 · strength 0.36
- Kathryn Elizabeth Mittauer · 2 shared papers, 2021–2023 · strength 0.30
- Paper Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness i… DOI 10.1016/j.radonc.2023.109869↗
- Paper Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenoca… DOI 10.1016/j.meddos.2021.04.006↗
- Russell F. Palm · 2 shared papers, 2022–2023 · strength 0.29
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Paper Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Re… DOI 10.1016/j.adro.2022.101045↗
- Jason B. Fleming · 2 shared papers, 2022–2023 · strength 0.29
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Paper Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Re… DOI 10.1016/j.adro.2022.101045↗
- Horacio J. Asbun · 1 shared paper, 2023 · strength 0.14
- Adeel Kaiser · 1 shared paper, 2023 · strength 0.14
- Dae Won Kim · 1 shared paper, 2023 · strength 0.14
- Delia G. Doty · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.